Skip to content
Wednesday, November 18, 2026
Modern Today Online

Individuals Discontinuing Weight-Loss Medications Gain Back Pounds at a Quadrupled Rate Compared to Those on Conventional Diets

Illustration of pharmaceutical injection and scale
Obesity treatment often requires ongoing approaches.

A recent study indicates that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds far faster than those who stop conventional lifestyle regimens.

Published data in a leading medical journal points out that while overweight individuals can lose substantial amounts of their body weight while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"People using such treatments must be cognizant of the danger of quick rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.

This pace of recovery implies a reversion to pre-treatment mass in about a year and a half.

Analyzing Treatments

The study, which looked at 37 of studies involving over 9,000 of participants, contrasted the results of the injectable medications with other pills.

The team note that individuals who lose weight through lifestyle changes alone typically see a slower creep back—around 100 grams monthly—once they finish.

Explaining the Fast Regain

Experts believe the mechanism of the drugs is key to understanding the accelerated weight return.

These medications copy a natural hormone called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its endogenous hormone, and may also reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this hormone supplement means hunger is uncontrolled, making excessive eating much more probable."

An Ongoing Condition?

The NHS recommend the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

Professionals argue that, due to the significant potential of weight regain, the therapy should be considered ongoing.

This opinion is reinforced by drug manufacturers, who state that the results "highlight the long-term nature of obesity," similar to managing conditions like hypertension.

User Experiences

Users who have stopped the medication report a powerful resurgence of appetite.

"It felt as if something that goes on and you become extremely hungry," said an individual.

This difficulty is compounded if patients have not established permanent lifestyle or habit modifications during treatment.

Growing Adoption

Recent estimates indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.

  • Use is greater among women than men.
  • The 40s and 50s age group shows the greatest level of interest.
  • Many access the medications through private prescriptions rather than the NHS.

Finally, experts caution that while the jabs are effective agents for weight loss, they are not a standalone solution and lasting health benefits relies on combined behavioural management.

The writer

Joshua Martinez

A tech-savvy lifestyle writer with a passion for exploring modern trends and sharing practical insights for everyday living.

Modern Today Online

Type to search articles.